Clinical Study of Universal CAR-γδT Cell Injection in the Treatment of Refractory and Relapsed AML Patients
Latest Information Update: 08 May 2024
At a glance
- Drugs Chimeric antigen receptor gamma delta T cell therapy-Hebei Senlang Biotechnology (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- Sponsors Hebei Senlang Biotechnology
Most Recent Events
- 31 May 2022 New trial record